CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Respirerx Pharmaceuticals Inc Company Snapshot
Respirerx Pharmaceuticals Inc operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Respirerx Pharmaceuticals Inc with three other companies in this sector in the United States: Boston Therapeutics Inc (2015 sales of $98,941.00 of which 100% was Sugardown TM), Cocrystal Pharma Inc ($78,000.00 ), and Endocyte, Inc. ($70,000.00 ).

Sales Analysis.
   
   
 
  Stock Performance Chart for Respirerx Pharmaceuticals Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 1.36
(Figures in U.S. Dollars)
1 Week 9.7%   13 Weeks -6.2%  
4 Weeks -22.3%   52 Weeks -65.6%  
 
Respirerx Pharmaceuticals Inc Key Data:
  Ticker: RSPI Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2015 Sales 86,916
(Year Ending Jan 2016).
Employees: 3
  Currency: U.S. Dollars Market Cap: 3,580,555
  Fiscal Yr Ends: December Shares Outstanding: 2,632,761
  Share Type: Closely Held Shares: 806,965
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.